Jama M. Darling

3.3k total citations
26 papers, 743 citations indexed

About

Jama M. Darling is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Jama M. Darling has authored 26 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 15 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Jama M. Darling's work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (7 papers). Jama M. Darling is often cited by papers focused on Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (7 papers). Jama M. Darling collaborates with scholars based in United States, Belgium and Germany. Jama M. Darling's co-authors include Ellen M. Gravallese, Laurie H. Glimcher, Amy L. Ladd, Jeffrey N. Katz, Michael Fried, Teresa L. Wright, Yoshitada Harada, Steven R. Goldring, M. Händel and Fred E. Shapiro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Jama M. Darling

23 papers receiving 724 citations

Peers

Countries citing papers authored by Jama M. Darling

Since Specialization

Citations

This map shows the geographic impact of Jama M. Darling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jama M. Darling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jama M. Darling more than expected).

Fields of papers citing papers by Jama M. Darling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jama M. Darling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jama M. Darling. The network helps show where Jama M. Darling may publish in the future.

Co-authorship network of co-authors of Jama M. Darling

This figure shows the co-authorship network connecting the top 25 collaborators of Jama M. Darling. A scholar is included among the top collaborators of Jama M. Darling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jama M. Darling. Jama M. Darling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study 2023 ·American Journal of Transplantation ·Wesam Aleyadeh, Elizabeth C. Verna, Hany Elbeshbeshy, Mark Sulkowski, Coleman I. Smith, Jama M. Darling, Richard K. Sterling, Andrew J. Muir, Lucy Akushevich, (unknown), Norah A. Terrault, Michael Fried, Jordan J. Feld	3
2	Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs 2023 ·Journal of General Internal Medicine ·(unknown), (unknown), (unknown), (unknown), Jama M. Darling, Christine Dunn, (unknown), (unknown), Asher J Schranz	5
3	Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients 2020 ·UNC Libraries ·(unknown), Michael Fried, (unknown), Jama M. Darling, (unknown), (unknown), (unknown), (unknown)	0
4	An Interaction Between Glecaprevir, Pibrentasvir, and Colchicine Causing Rhabdomyolysis in a Patient With Chronic Renal Disease 2020 ·Clinical Liver Disease ·(unknown), (unknown), Jama M. Darling	0
5	Daclatasvir and sofosbuvir treatment of decompensated liver disease or post‐liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real‐world cohort 2018 ·Hepatology Communications ·Paul Y. Kwo, Michael Fried, K. Rajender Reddy, Consuelo Soldevila‐Pico, Saro Khemichian, Jama M. Darling, (unknown), Andrew Napoli, (unknown), Robert S. Brown	8
6	Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study 2016 ·Gut ·Tania M. Welzel, David R. Nelson, Giuseppe Morelli, Adrian M. Di Bisceglie, K. Rajender Reddy, Alexander Kuo, Joseph K. Lim, Jama M. Darling, Paul J. Pockros, Joseph Galati, Lynn M. Frazier, Saleh A. Alqahtani, Mark Sulkowski, Monika Vainorius, Lucy Akushevich, Michael Fried, Stefan Zeuzem	61
7	High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV‐infected patients regardless of DPP4 activity 2015 ·Liver International ·S. Johansson, Willem Talloen, Marianne Tuefferd, Jama M. Darling, Gregory Fanning, Michael Fried, Jeroen Aerssens	4
8	Plasma levels of growth‐related oncogene (CXCL1‐3) associated with fibrosis and platelet counts in HCV‐infected patients 2015 ·Alimentary Pharmacology & Therapeutics ·S. Johansson, Willem Talloen, Marianne Tuefferd, Jama M. Darling, Annick Scholliers, (unknown), Michael Fried, Jeroen Aerssens	18
9	Membranoproliferative Glomerulonephritis, Type II Cryoglobulinemia and Triple Therapy for Hepatitis C: A Case Series and Review of the Literature 2014 ·Digestive Diseases and Sciences ·(unknown), Jama M. Darling, A. Sidney Barritt	6
10	Overlap syndrome of autoimmune chronic liver diseases: MRI findings 2010 ·Journal of Magnetic Resonance Imaging ·W. Brian Hyslop, Andrea S. Kierans, Polytimi Leonardou, Karen Fritchie, Jama M. Darling, (unknown), Richard C. Semelka	11
11	Quantitation of pretreatment serum interferon-γ–inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response 2010 ·Hepatology ·Jama M. Darling, Jeroen Aerssens, Gregory Fanning, John G. McHutchison, David B. Goldstein, Alexander Thompson, Kevin V. Shianna, Nezam H. Afdhal, (unknown), Charles D. Howell, Willem Talloen, Jacques Bollekens, Mieke De Wit, Annick Scholliers, Michael Fried	88
12	Optimizing Treatment Regimens in Hepatitis C 2006 ·Clinics in Liver Disease ·Jama M. Darling, Michael Fried	13
13	Immune responses in hepatitis C: is virus or host the problem? 2004 ·Current Opinion in Infectious Diseases ·Jama M. Darling, Teresa L. Wright	11
14	Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies 2003 ·Proceedings of the National Academy of Sciences ·Nam‐On Ku, Jama M. Darling, Sheri M. Krams, Carlos O. Esquivel, Emmet B. Keeffe, Richard K. Sibley, Young Moo Lee, Teresa L. Wright, M. Bishr Omary	79
15	A blood‐borne antigen induces rapid T–B cell contact: a potential mechanism for tolerance induction 2002 ·Immunology ·Ines Gütgemann, Jama M. Darling, Harry B. Greenberg, Mark M. Davis, Yueh‐hsiu Chien	9
16	α4β7 independent pathway for CD8+ T cell–mediated intestinal immunity to rotavirus 2000 ·Journal of Clinical Investigation ·Nelly A. Kuklin, Lusijah Rott, Jama M. Darling, James J. Campbell, M. Franco, Ningguo Feng, Werner Müller, Norbert Wagner, John D. Altman, Eugene C. Butcher, Harry B. Greenberg	47
17	Expression of metalloproteinases in pigmented villonodular synovitis 1994 ·Human Pathology ·Jama M. Darling, Laurie H. Glimcher, Sonya Shortkroff, (unknown), Ellen M. Gravallese	19
18	In situ hybridization studies suggest a role for the basic region‐leucine zipper protein hXBP‐1 in exocrine gland and skeletal development during mouse embryogenesis 1993 ·Developmental Dynamics ·I. Clauss, Ellen M. Gravallese, Jama M. Darling, Fred E. Shapiro, Melvin J. Glimcher, Laurie H. Glimcher	78
19	In Situ Hybridization Studies of Stromelysin and Collagenase Messenger RNA Expression in Rheumatoid Synovium 1991 ·Arthritis & Rheumatism ·Ellen M. Gravallese, Jama M. Darling, Amy L. Ladd, Jeffrey N. Katz, Laurie H. Glimcher	179
20	Role of lipopolysaccharide and IL-4 in control of transcription of the class II A alpha gene 1991 ·The Journal of Immunology ·Ellen M. Gravallese, Jama M. Darling, Laurie H. Glimcher, Mark Boothby	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact